FYB1 and COVID-19: The trend toward overrepresentation of the Fy(a+b-) predicted phenotype among our COVID-19 convalescent cohort could be explained by the absence of the Fyb antigen, since no significant difference was observed when comparing Fy(a+b+) and Fy(a-b+).